A detailed history of Laird Norton Trust Company, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 25,000 shares of NVNO stock, worth $65,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,000
Previous 33,000 24.24%
Holding current value
$65,000
Previous $173,000 51.45%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.24 - $6.19 $25,920 - $49,520
-8,000 Reduced 24.24%
25,000 $84,000
Q1 2024

May 15, 2024

BUY
$3.94 - $6.65 $90,620 - $152,950
23,000 Added 230.0%
33,000 $179,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.73 $34,600 - $57,300
10,000 New
10,000 $51,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $24.6M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Laird Norton Trust Company, LLC Portfolio

Follow Laird Norton Trust Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laird Norton Trust Company, LLC with notifications on news.